Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Puma Biotechnology
PBYI
|
+$276M |
| 2 |
Home Depot
HD
|
+$240M |
| 3 |
TE Connectivity
TEL
|
+$232M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$191M |
| 5 |
SHPG
Shire pic
SHPG
|
+$181M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$279M |
| 2 |
Meta Platforms (Facebook)
META
|
+$271M |
| 3 |
NVIDIA
NVDA
|
+$233M |
| 4 |
Cadence Design Systems
CDNS
|
+$222M |
| 5 |
CSX Corp
CSX
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.46% |
| 2 | Healthcare | 15.52% |
| 3 | Financials | 13.32% |
| 4 | Industrials | 12.73% |
| 5 | Consumer Discretionary | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Canadian Pacific Kansas City
CP
$82B
| $120M | 0.07% |
3,289,505
+77,340
| +2% | +$2.69M |
|
327
Protolabs
PRLB
$1.86B
| $120M | 0.07% |
1,165,402
-51,794
| -4% | -$4.65M |
|
328
Annaly Capital Management
NLY
$16.9B
| $120M | 0.07% |
2,517,881
+635,711
| +34% | +$30.2M |
|
329
Expedia Group
EXPE
$31.2B
| $120M | 0.07% |
997,935
+445,563
| +81% | +$57.8M |
|
|
GBT
330
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $119M | 0.07% |
3,028,782
+1,613,224
| +114% | +$60.3M |
|
331
Kennametal
KMT
$2.68B
| $119M | 0.07% |
2,460,439
-49,079
| -2% | -$2.19M |
|
332
Edison International
EIX
$30.7B
| $119M | 0.07% |
1,880,756
+240,999
| +15% | +$18.4M |
|
333
Chubb
CB
$140B
| $118M | 0.07% |
810,353
-130,875
| -14% | -$19.6M |
|
|
AVXS
334
DELISTED
AveXis, Inc. Common Stock
AVXS
| $118M | 0.07% |
1,068,779
+41,558
| +4% | +$4.17M |
|
|
HI
335
DELISTED
Hillenbrand
HI
| $118M | 0.07% |
2,636,759
-12,013
| -0.5% | -$503K |
|
336
Check Point Software Technologies
CHKP
$13.3B
| $118M | 0.07% |
1,136,916
-136,917
| -11% | -$14.9M |
|
|
FNGN
337
DELISTED
Financial Engines, Inc.
FNGN
| $118M | 0.07% |
3,886,896
+651,231
| +20% | +$20.5M |
|
338
Stanley Black & Decker
SWK
$14.2B
| $118M | 0.07% |
693,613
+58,973
| +9% | +$9.65M |
|
339
Compass Minerals
CMP
$1.24B
| $117M | 0.07% |
1,616,197
+129,372
| +9% | +$8.71M |
|
340
Cigna
CI
$76.6B
| $116M | 0.07% |
570,944
+355,520
| +165% | +$70.8M |
|
|
CALD
341
DELISTED
Callidus Software, Inc.
CALD
| $115M | 0.07% |
4,026,672
+457,545
| +13% | +$12.5M |
|
342
Dell
DELL
$283B
| $115M | 0.07% |
5,048,531
-891,255
| -15% | -$20.2M |
|
|
NVRO
343
DELISTED
NEVRO CORP.
NVRO
| $114M | 0.07% |
1,652,556
+403,189
| +32% | +$32.3M |
|
|
FOLD
344
DELISTED
Amicus Therapeutics
FOLD
| $114M | 0.07% |
7,916,701
+482,387
| +6% | +$6.63M |
|
|
ABMD
345
DELISTED
Abiomed Inc
ABMD
| $114M | 0.07% |
607,143
-469,686
| -44% | -$87.7M |
|
346
Yum China
YUMC
$14.9B
| $113M | 0.07% |
2,819,055
+1,222,217
| +77% | +$50.3M |
|
347
Xylem
XYL
$28.5B
| $113M | 0.07% |
1,653,529
+395,242
| +31% | +$26.2M |
|
348
Sally Beauty Holdings
SBH
$1.4B
| $113M | 0.07% |
5,999,340
-2,443,341
| -29% | -$42.3M |
|
349
Visteon
VC
$2.77B
| $111M | 0.07% |
883,839
+58,267
| +7% | +$7.38M |
|
350
H.B. Fuller
FUL
$3B
| $110M | 0.07% |
2,038,098
+87,112
| +4% | +$4.84M |
|
Similar funds
Janus Henderson Group's Q4 2017 Portfolio in Review
As of Q4 2017, Janus Henderson Group held 1,379 positions worth $165B, up 5.4% from $156B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q4 2017 filing shows 95 new, 535 increased, 621 reduced and 76 closed positions. Its largest new stake was Invitation Homes: 5,558,350 shares worth $131M. The largest sale was Lowe's Companies, an estimated $279M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q4 2017 buy was Invitation Homes: 5,558,350 shares worth $131M.
- Janus Henderson Group added most to Puma Biotechnology in Q4 2017, an estimated $276M increase.
- Janus Henderson Group's biggest Q4 2017 reduction was Lowe's Companies, cutting an estimated $279M.
- Janus Henderson Group fully exited CR Bard Inc. in Q4 2017, selling an estimated $124M.
- Janus Henderson Group's ten largest holdings make up 14% of its $165B portfolio in Q4 2017.
- Janus Henderson Group opened 95 new positions and closed 76 in Q4 2017.
- Janus Henderson Group's portfolio value rose 5.4% quarter-over-quarter to $165B.
Based on Janus Henderson Group's 13F filing for Q4 2017, filed 9 Feb 2018.